XML 13 R3.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Revenues $ 6,437 $ 481
Operating expenses:    
Research and development 26,006 35,891
General and administrative 10,059 11,767
Impairment of long-lived assets 0 4,349
Total operating expenses 36,065 52,007
Loss from operations (29,628) (51,526)
Interest income 309 451
Other (expense) income, net (1,159) 2,084
Loss before income taxes (30,478) (48,991)
Income tax expense 119 98
Net income (loss) $ (30,597) $ (49,089)
Earnings Per Share [Abstract]    
Basic net loss per share (in dollars per share) $ (0.14) $ (0.27)
Diluted net loss per share (in dollars per share) $ (0.14) $ (0.27)
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]    
Weighted average number of shares outstanding - basic (in shares) 220,269 180,342
Weighted average number of shares outstanding - diluted (in shares) 220,269 180,342